Evidence map›Paper›PMID 32025166›Full record

ReviewJournal of clinical and experimental hepatology

2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Ashish Kumar, Subrat K Acharya, Shivaram P Singh, Anil Arora, Radha K Dhiman, Rakesh Aggarwal, Anil C Anand, Prashant Bhangui, Yogesh K Chawla, Siddhartha Datta Gupta and 23 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. International perspectives on LI-RADS.Abdominal radiology (New York) · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Multi-center prospective survey of hepatocellular carcinoma in Kerala: More than 1,200 cases.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2023
    Article
  11. Review
  12. Article
  13. Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  14. Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2022
    Observational
  15. Article
  16. Review
  17. Review
  18. Review
  19. Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021
    Observational
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Ashish KumarInstitute of Liver Gastroenterology & Pancreatico Biliary Sciences, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110 060, India.
Subrat K AcharyaDepartment of Gastroenterology and Hepatology, KIIT University, Patia, Bhubaneswar, Odisha, 751 024, India.
Shivaram P SinghDepartment of Gastroenterology, SCB Medical College, Cuttack, Dock Road, Manglabag, Cuttack, Odisha, 753 007, India.
Anil AroraInstitute of Liver Gastroenterology & Pancreatico Biliary Sciences, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110 060, India.
Radha K DhimanDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India.
Rakesh AggarwalDepartment of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow, Uttar Pradesh, 226 014, India.
Anil C AnandDepartment of Gastroenterology, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi, 110 076, India.
Prashant BhanguiMedanta Institute of Liver Transplantation and Regenerative Medicine, Medanta the Medicity, CH Baktawar Singh Road, Sector 38, Gurugram, Haryana, 122 001, India.
Yogesh K ChawlaDepartment of Gastroenterology, Kalinga Institute of Medical Sciences (KIMS), Kushabhadra Campus (KIIT Campus-5), Patia, Bhubaneswar, Odisha, 751 024, India.
Siddhartha Datta GuptaDepartment of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029, India.
Vinod K DixitDepartment of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, 221 005, India.
Ajay DusejaDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India.
Naveen KalraDepartment of Radio Diagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India.
Premashish KarDepartment of Gastroenterology and Hepatology, Max Super Speciality Hospital, Vaishali, Ghaziabad, Uttar Pradesh, 201 012, India.
Suyash S KulkarniDivision of Interventional Radiology, Tata Memorial Hospital, Dr. E Borges Road, Parel, Mumbai, Maharashtra, 400 012, India.
Rakesh KumarDepartment of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029, India.
Manoj KumarDepartment of Hepatology, Institute of Liver & Biliary Sciences, Sector D-1, Vasant Kunj, New Delhi, 110 070, India.
Ram MadhavanDepartment of Radiation Oncology, Amrita Institute of Medical Sciences, Amrita University, Peeliyadu Road, Ponekkara, Edappally, Kochi, Kerala, 682 041, India.
V G Mohan PrasadDepartment of Gastroenterology, VGM Gastro Centre, 2100, Trichy Road, Rajalakshmi Mills Stop, Singanallur, Coimbatore, Tamil Nadu, 641 005, India.
Amar MukundDepartment of Radiology, Institute of Liver & Biliary Sciences, Sector D-1, Vasant Kunj, New Delhi, 110 070, India.
Aabha NagralDepartment of Gastroenterology, Jaslok Hospital & Research Centre, 15, Dr Deshmukh Marg, Pedder Road, Mumbai, Maharashtra, 400 026, India.
Dipanjan PandaDepartment of Oncology, Institutes of Cancer, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi, 110 076, India.
Shashi B PaulDepartment of Radiodiagnosis, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029, India.
Padaki N RaoDepartment of Medical Gastroenterology, Asian Institute of Gastroenterology, No. 6-3-661, Punjagutta Road, Somajiguda, Hyderabad, Telangana, 500 082, India.
Mohamed RelaThe Institute of Liver Disease & Transplantation, Gleneagles Global Health City, 439, Cheran Nagar, Perumbakkam, Chennai, Tamil Nadu, 600 100, India.
Manoj K SahuDepartment of Medical Gastroenterology, IMS & SUM Hospital, K8 Kalinga Nagar, Shampur, Bhubaneswar, Odisha 751 003, India.
Vivek A SaraswatDepartment of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow, Uttar Pradesh, 226 014, India.
Samir R ShahDepartment of Gastroenterology, Jaslok Hospital & Research Centre, 15, Dr Deshmukh Marg, Pedder Road, Mumbai, Maharashtra, 400 026, India.
ShalimarDepartment of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110 029, India.
Praveen SharmaInstitute of Liver Gastroenterology & Pancreatico Biliary Sciences, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110 060, India.
Sunil TanejaDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India.
Manav WadhawanLiver & Digestive Diseases Institute, Institute of Liver & Digestive Diseases, BLK Super Specialty Hospital, Delhi, 110 005, India.
INASL Task-Force on Hepatocellular Carcinoma

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is one of the major causes of morbidity, mortality, and healthcare expenditure in patients with chronic liver disease in India. The Indian National Association for Study of the Liver (INASL) had published its first guidelines on diagnosis and management of HCC (The Puri Recommendations) in 2014, and these guidelines were very well received by the healthcare community involved in diagnosis and management of HCC in India and neighboring countries. However, since 2014, many new developments have taken place in the field of HCC diagnosis and management, hence INASL endeavored to update its 2014 consensus guidelines. A new Task Force on HCC was constituted that reviewed the previous guidelines as well as the recent developments in various aspects of HCC that needed to be incorporated in the new guidelines. A 2-day round table discussion was held on 5th and 6th May 2018 at Puri, Odisha, to discuss, debate, and finalize the revised consensus statements. Each statement of the guideline was graded according to the Grading of Recommendations Assessment Development and Evaluation system with minor modifications. We present here the 2019 Update of INASL Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri-2 Recommendations.

Indexed as

AFP, alpha-fetoproteinAIH, autoimmune hepatitisALT, alanine aminotransferaseDAA, direct-acting antiviralDALY, disability-adjusted life-yearDNA, deoxyribonucleic acidGd-BOPTA, gadolinium benzyloxypropionictetraacetateGd-EOB-DTPA, gadolinium ethoxybenzyl diethylenetriamine penta-acetic acidGRADE, Grading of Recommendations Assessment Development and EvaluationHBeAg, hepatitis B envelope antigenHBV, hepatitis B virusHCC, hepatocellular carcinomaHIV, human immunodeficiency virusIARC, International Agency for Research on CancerIFN, interferonINASL, Indian National Association for Study of the Liverliver cancerMiRNA, micro-RNANAFLD, non-alcoholic fatty liver diseaseNASH, non-alcoholic steatohepatitisPIVKA, protein induced by vitamin K absenceRFARNA, ribonucleic acidSVR, sustained virological responseTACETACE, trans-arterial chemoembolizationTARE, transarterial radioembolizationtargeted therapyTNF, tumor necrosis factortransplantWHO, World Health Organization

Identifiers

PMID32025166
PMCPMC6995891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.